Skip to main content

Profile hero

Profile details

About Dr. Eva-Maria Hoyler

Eva is an M&A senior associate in our global transactions team. She advises financial sponsors and corporate clients on national and cross-border M&A, private equity and carve-out transactions across a variety of sectors, with a particular focus on the life sciences and technology sectors.

In 2021/2022, Eva was seconded to KKR in London where she advised on private equity, infrastructure, healthcare growth und tech growth transactions in EMEA.

She speaks German, English, French, Spanish and Greek.

Recent work


  • the then-current shareholders of MYR GmbH on their sale of MYR to Gilead for approx. EUR 1.5 billion; MYR is a German biotechnology company focused on the development and commercialisation of therapeutics for the treatment of chronic hepatitis delta virus (HDV);
  • KKR on various proposed acquisitions across sectors and strategies;
  • Advent on
    • its acquisition of the methacrylates business from Evonik Industries AG for EUR 3 billion,
    • its acquisition of Deutsche Fachpflege Gruppe, a provider of non-clinical intensive care in Germany, and
    • various proposed acquisitions;
  • Francisco Partners, a leading global investment firm specialised in partnering with technology and technology-enabled businesses, on its acquisition of a majority stake in Native Instruments, a provider of soft- and hardware for digital music production;
  • BBVA on its follow-on investment in
    • the EUR 190 million series D round of solarisBank AG, Europe’s leading Banking-as-a-Service platform, valuing the company at EUR 1.4 billion, and
    • the EUR 60 million series C round of solarisBank AG;
  • Verisk Analytics, a leading data analytics provider, on
    • its acquisition of the content as a service business of SAP and a strategic partnership for product compliance solutions, and
    • its acquisition of the German part of Genscape's energy data business from Daily Mail and General Trust;
  • Axel Springer on its joint acquisition with Purplebricks of an interest in Homeday, a transaction-based digital real estate platform;
  • Merck KGaA on the carve-out and sale of its global consumer health business (spanning across more than 50 jurisdictions and including listed subsidiaries in India and Indonesia) to Procter & Gamble (P&G) for approx. EUR 3.4 billion;
  • ABB on the carve-out and sale of its global high-voltage cable business with a total enterprise value of EUR 836 million (USD 934 million);
  • LG Corporation and LG Electronics on the acquisition of ZKW, an Austrian automotive lighting system manufacturer, for EUR 1.1 billion;
  • Vattenfall on the carve-out and sale of its lignite power plants and open cast mines to the Czech energy supplier Energetický a průmyslový holding (EPH) and the financial investor PPF Investments;
  • enercity (Stadtwerke Hannover Aktiengesellschaft) on the sale of the hard coal power plant Mehrum to the Czech energy supplier Energetický a průmyslový holding (EPH); and
  • 3i on the acquisition of automotive supplier Schlemmer.



  • Scholar of the German Academic Scholarship Foundation (Studienstiftung des deutschen Volkes)
  • Scholar of the Paul and Yvonne Gillet Foundation


  • Bucerius Law School, Hamburg, Germany (First State Exam)
  • University of Paris Panthéon-Sorbonne, France
  • PhD degree from the Bucerius Law School, Hamburg, Germany (doctor of laws - Dr iur
  • Higher Regional Court of Hamburg, Germany, legal traineeship (Referendariat) working, amongst others, in the M&A practice group of the Freshfields’ Berlin office and for the Federal Foreign Office in Berlin
  • Higher Regional Court of Hamburg, Germany (Second State Exam)

Professional qualifications

  • Rechtsanwältin, Germany